Anti-RNF215 monoclonal antibody
Pre-made anti-RNF215 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to RNF215/RNF215 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1525-Ab-1/ GM-Tg-hg-IP1525-Ab-2 | Anti-Human RNF215 monoclonal antibody | Human |
GM-Tg-rg-IP1525-Ab-1/ GM-Tg-rg-IP1525-Ab-2 | Anti-Rat RNF215 monoclonal antibody | Rat |
GM-Tg-mg-IP1525-Ab-1/ GM-Tg-mg-IP1525-Ab-2 | Anti-Mouse RNF215 monoclonal antibody | Mouse |
GM-Tg-cynog-IP1525-Ab-1/ GM-Tg-cynog-IP1525-Ab-2 | Anti-Cynomolgus/ Rhesus macaque RNF215 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1525-Ab-1/ GM-Tg-felg-IP1525-Ab-2 | Anti-Feline RNF215 monoclonal antibody | Feline |
GM-Tg-cang-IP1525-Ab-1/ GM-Tg-cang-IP1525-Ab-2 | Anti-Canine RNF215 monoclonal antibody | Canine |
GM-Tg-bovg-IP1525-Ab-1/ GM-Tg-bovg-IP1525-Ab-2 | Anti-Bovine RNF215 monoclonal antibody | Bovine |
GM-Tg-equg-IP1525-Ab-1/ GM-Tg-equg-IP1525-Ab-2 | Anti-Equine RNF215 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP1525-Ab-1/ GM-Tg-hg-IP1525-Ab-2;
GM-Tg-rg-IP1525-Ab-1/ GM-Tg-rg-IP1525-Ab-2; GM-Tg-mg-IP1525-Ab-1/ GM-Tg-mg-IP1525-Ab-2; GM-Tg-cynog-IP1525-Ab-1/ GM-Tg-cynog-IP1525-Ab-2; GM-Tg-felg-IP1525-Ab-1/ GM-Tg-felg-IP1525-Ab-2; GM-Tg-cang-IP1525-Ab-1/ GM-Tg-cang-IP1525-Ab-2; GM-Tg-bovg-IP1525-Ab-1/ GM-Tg-bovg-IP1525-Ab-2; GM-Tg-equg-IP1525-Ab-1/ GM-Tg-equg-IP1525-Ab-2 |
Products Name | Anti-RNF215 monoclonal antibody |
Format | mab |
Target Name | RNF215 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) |
IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-RNF215 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
- Figure A: GeneMedi's GMP-h-p-tau181-Ab01 (Anti-human p-tau181 antibody) is validated to detect the GMP-h-p-tau181-Ag01 (p-tau181 antigen) in ELISA, EC50 = 25.26ng/ml.
- Figure B: GeneMedi's GMP-h-p-tau217-Ab01 (Anti-human p-tau217 antibody) is validated to detect the GMP-h-p-tau217-Ag01 (p-tau217 antigen) in ELISA, EC50 = 25.85ng/ml.
- Figure C: GeneMedi's GMP-h-p-tau231-Ab01 (Anti-human p-tau231 antibody) is validated to detect the GMP-h-p-tau231-Ag01 (p-tau231 antigen) in ELISA. EC50 = 64.34ng/ml.
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP1525-Ag-1 | Recombinant multi-species RN215/ RNF215 protein |
Target information
Target ID | GM-IP1525 |
Target Name | RNF215 |
Gene ID | 200312,71673,305478,715696,486351,101091482,530174,100063936 |
Gene Symbol and Synonyms | 0610009J22Rik,RGD1310738,RNF215 |
Uniprot Accession | Q9Y6U7 |
Uniprot Entry Name | RN215_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000099999 |
Target Classification | N/A |
The target: RNF215, gene name: RNF215, also named as . Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in Golgi to vacuole transport; protein targeting to vacuole; and ubiquitin-dependent protein catabolic process. Predicted to be integral component of membrane. Predicted to be part of Golgi transport complex. Predicted to be active in endosome; membrane; and trans-Golgi network. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant
monoclonal antibodies, each meticulously designed to target specific molecular
entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies characterized by high binding affinity,
exceptional physicochemical stability, and optimal developability
profiles.
Through expression in mammalian cell lines, GMab has been
established as a paradigmatic reference antibody. It holds significance in myriad
domains of biological drug discovery, encompassing cellular cultivation, innovative
assay methodologies, strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.